| NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors (NCT05252390) | Nuvation Bio Inc. | 2022-03-29 |
| Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors (NCT04541225) | Nuvation Bio Inc. | 2020-12-08 |
| MRI/Ultrasound Fusion Guided Laser Ablation of Prostate Cancer (NCT05241236) | Urological Research Network, LLC | 2020-11-15 |
| I-131-1095 Radioligand Plus Enzalutamide vs Enzalutamide for mCRPC That Progressed During Abiraterone (ARROW). (NCT03939689) | Progenics Pharmaceuticals, Inc. | 2019-05-30 |
| High Intensity Interval Training (HIIT) for Patients With Cancer-related Lymphedema in the Lower Limbs (NCT03653819) | Herlev and Gentofte Hospital | 2018-09-06 |
| Proton Boost in Prostate Cancer (NCT03564275) | University of Cincinnati | 2018-04-16 |
| A Trial of 177Lu-PSMA617 Theranostic Versus Cabazitaxel in Progressive Metastatic Castration Resistant Prostate Cancer (NCT03392428) | Australian and New Zealand Urogenital and Prostate Cancer Trials Group | 2018-01-29 |
| Gadoxetate Sodium Enhanced MRI as a Biomarker for Aggressive Prostate Cancer (NCT03960788) | University of Cincinnati | 2018-01-02 |
| Decision Impact Trial of the ExoDx Prostate (IntelliScore) (NCT03235687) | Exosome Diagnostics, Inc. | 2017-07-19 |
| Prostate Cancer Survivors and Exercise and Behavioral Counseling (NCT03191968) | University of Illinois at Urbana-Champaign | 2017-07-06 |
| Neoadjuvant Apalutamide (ARN509) and Radical Prostatectomy in Treatment of Intermediate to High Risk Prostate Cancer (NCT03124433) | Singapore General Hospital | 2017-06-20 |
| MR-simulation in Radiotherapy for Prostate Cancer (NCT03238170) | Guy's and St Thomas' NHS Foundation Trust | 2017-03-01 |
| Cognitive Remediation Therapy (CRT) for Adults Treated for Cancer (NCT03285048) | Yale University | 2017-01-01 |
| Urology of Virginia Case Series (NCT03035487) | Exact Imaging | 2016-12-01 |
| Investigation of Metformin in Patients With Castration Resistant Prostate Cancer in Combination With Enzalutamide vs. Enzalutamide Alone (NCT02640534) | Swiss Cancer Institute | 2016-06-10 |
| Comparison Of DIR-MRI And DCE-MRI In Detection Of Prostate Cancer: A Pilot Study (NCT02939456) | University Hospitals of North Midlands NHS Trust | 2016-06-01 |
| European Randomised Study of TOOKAD® Soluble for Prostate Cancer vs Active Surveillance. Post Study Follow-up (NCT04017325) | Steba Biotech S.A. | 2016-03-17 |
| Optimizing the Effectiveness of Routine Post-treatment Surveillance in Prostate Cancer Survivors (NCT02957357) | Alliance Foundation Trials, LLC. | 2016-02-01 |
| Fluciclovine (18F) PET/CT in biochemicAL reCurrence Of Prostate caNcer (NCT02578940) | Blue Earth Diagnostics | 2015-11-01 |
| Maintaining Suppression of Testosterone With Transdermal Estradiol Gel (NCT02349386) | BHR Pharma, LLC | 2015-07-01 |
| The Herlev Hospital Post Radiation Therapy for Localized Prostate Cancer Database for Sexual Side Effects (NCT02274350) | Herlev Hospital | 2015-05-01 |
| Safety, Preliminary Efficacy and Pharmacokinetics of ASN001 in Metastatic Castrate Resistant Prostate Cancer (NCT02349139) | Asana BioSciences | 2015-01-19 |
| Evaluation of the Accuracy of the Elastic Fusion MRI-ultrasound Obtained in Vivo by the Koelis™ System (NCT02879851) | Hospices Civils de Lyon | 2015-01-01 |
| Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK) (NCT02319837) | Pfizer | 2014-12-17 |
| Stereotactic Body Radiotherapy for Stage I-III Prostate Cancer (NCT02334579) | Swedish Medical Center | 2014-12-01 |
| Multi-Center Trial of High-resolution Transrectal Ultrasound Versus Standard Low-resolution Transrectal Ultrasound for the Identification of Clinically Significant Prostate Cancer (NCT02079025) | Exact Imaging | 2013-12-01 |
| PCa Patients Managed With ADT to Examine the Effect of Nutritional Guidance and Aerobic/Resistance Fitness Training (NCT04057859) | CMX Research | 2013-11-01 |
| Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer (NCT02003924) | Pfizer | 2013-10-31 |
| MRI/Ultrasound Fusion Guided Prostate Cryotherapy (NCT02381990) | Urological Research Network, LLC | 2013-08-01 |
| Hemi-Ablative Prostate Brachytherapy (NCT02632669) | Royal Surrey County Hospital NHS Foundation Trust | 2012-07-06 |
| Sipuleucel-T Manufacturing Demonstration Study (NCT01477749) | Dendreon | 2012-06-01 |
| Prostate-Rectal Separation With PEG Hydrogel and Its Effect on Decreasing Rectal Dose (NCT02212548) | Royal North Shore Hospital | 2012-03-01 |
| North Carolina Prostate Cancer Comparative Effectiveness & Survivorship Study (NC ProCESS) (NCT02564120) | UNC Lineberger Comprehensive Cancer Center | 2011-01-01 |
| Anti-OX40, Cyclophosphamide (CTX) and Radiation in Patients With Progressive Metastatic Prostate Cancer (NCT01303705) | Providence Health & Services | 2010-10-14 |
| Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer (NCT00970203) | Roswell Park Cancer Institute | 2009-09-01 |
| Eligard Observational Registry for Patients With Prostate Cancer (NCT00992251) | CMX Research | 2009-08-01 |
| Study of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate Cancer (NCT00844792) | University Health Network, Toronto | 2008-10-01 |
| Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance (NCT00744549) | University Health Network, Toronto | 2008-05-01 |
| A Phase II Trial of CyberKnife Stereotactic Radiosurgery to Prostate Tumors (NCT02225262) | Community Cancer Center, Normal, Illinois | 2008-01-01 |
| CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution (NCT00643994) | Accuray Incorporated | 2007-12-01 |
| Multicentric Study Comparing Carcinological and Functional Results of Surgery (NCT00502723) | Assistance Publique - Hôpitaux de Paris | 2007-12-01 |
| A Phase 2 Study to Investigate the Clinical Activity of IPI-504 in Patients With Hormone-resistant Prostate Cancer (NCT00564928) | Infinity Pharmaceuticals, Inc. | 2007-11-01 |
| CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry (NCT00643617) | Accuray Incorporated | 2007-10-22 |
| Vessel Sparing Prostate Radiation Therapy (NCT02958787) | University of Michigan Rogel Cancer Center | 2004-11-01 |
| Phase I/II Study of Vaccination With Antigen Loaded Dendritic Cells (DCs) in Hormone-Refractory Prostate Cancer (NCT01897207) | Cantonal Hospital of St. Gallen | 2002-11-01 |
| Detecting Recurrent Prostate Cancer With C-11 Choline Positron Emission Tomography: An Expanded Access Study (NCT02355054) | Washington University School of Medicine | |
| A Study for the Treatment of Hormone Refractory Prostate Cancer (HRPC) in Patients Previously Treated With Chemotherapy (NCT00257478) | Astellas Pharma Inc | |